Sign In

Jeff Albers

Chief Executive Officer at Blueprint Medicines

Jeff Albers is a prominent figure in the life sciences industry with a unique blend of business and legal expertise.

He transitioned from a successful career as a corporate attorney in life sciences to executive positions focusing on commercial and business development.

His diverse commercial background encompasses areas such as sales, marketing, managed markets, and operations, showcasing a well-rounded skill set.

Albers pursued his education at esteemed institutions including Georgetown University McDonough School of Business (MBA), Georgetown University Law Center (JD), and Indiana University Bloomington (BS in Marketing).

He has held significant roles in various organizations, including serving as a Board Member at Kymera Therapeutics, former Board Member at Magenta Therapeutics, Chief Executive Officer at Blueprint Medicines, President, US at Algeta ASA, Vice President, US Hematology & Oncology at Genzyme, Sr. Director of Corporate Development/Genzyme Ventures at Genzyme, Associate at Mintz, Levin, Cohn, Ferris, Glovsky & Popeo, and Professional Healthcare Representative at Pfizer.

Jeff Albers
Add to my network

Location

Greater Boston Area